Amarin Completes All Non-Clinical Work for AMR101 NDA Submission Submitted by amarin on Fri, 12/08/2017 - 04:48 Home Read more about Amarin Completes All Non-Clinical Work for AMR101 NDA Submission
Amarin Announces Proposed Public Offering of American Depositary Shares Submitted by amarin on Fri, 12/08/2017 - 04:48 Home Read more about Amarin Announces Proposed Public Offering of American Depositary Shares
Amarin Prices Public Offering of American Depositary Shares Submitted by amarin on Fri, 12/08/2017 - 04:48 Home Read more about Amarin Prices Public Offering of American Depositary Shares
Amarin Announces Underwriters' Exercise of Over-Allotment Option Submitted by amarin on Fri, 12/08/2017 - 04:48 Home Read more about Amarin Announces Underwriters' Exercise of Over-Allotment Option
Amarin Announces Successful Completion of Offering of American Depositary Shares Submitted by amarin on Fri, 12/08/2017 - 04:48 Home Read more about Amarin Announces Successful Completion of Offering of American Depositary Shares
Amarin Provides 2010 Year-End Review to Shareholders Submitted by amarin on Fri, 12/08/2017 - 04:48 Home Read more about Amarin Provides 2010 Year-End Review to Shareholders
Amarin Corporation Appoints Industry Veteran Paul E. Huff as Chief Commercial Officer Submitted by amarin on Fri, 12/08/2017 - 04:48 Home Read more about Amarin Corporation Appoints Industry Veteran Paul E. Huff as Chief Commercial Officer
Amarin to Present at the Leerink Swann Hot Topics in Therapeutics Roundtable Conference Submitted by amarin on Fri, 12/08/2017 - 04:48 Home Read more about Amarin to Present at the Leerink Swann Hot Topics in Therapeutics Roundtable Conference
Amarin to Present at Two Upcoming Investor Conferences Submitted by amarin on Fri, 12/08/2017 - 04:48 Home Read more about Amarin to Present at Two Upcoming Investor Conferences
Amarin to Present at Two Upcoming Investor Conferences Submitted by amarin on Fri, 12/08/2017 - 04:48 Home Read more about Amarin to Present at Two Upcoming Investor Conferences
